Enterprise Security
Identity-Based Segmentation Deployed Across 17 Global Sites. R&D And Scientific Assets Secured.
Pfizer
Role
17 global site locations operating on legacy perimeter security with no device identity enforcement and no granular policy control over R&D bench-top and scientific device assets
Research environments requiring zero disruption across active bench-top operations during a multi-site phased rollout
No consistent segmentation architecture or policy standardization across global locations
“
Solution
Algorama engineered and deployed Elisity identity-based segmentation across 17 Pfizer site locations in a nine-month phased engagement. Attribute-based policy enforcement was established across device and identity dimensions, covering R&D bench-top and scientific device assets across all locations. All work executed remotely with zero disruption to active research environments.
Key Wins
17 global sites operating under identity-based segmentation
R&D bench-top and scientific device assets secured with attribute-based policy enforcement
Legacy perimeter architecture transitioned to zero-trust segmentation
Tech Stack:
Elisity
Cisco VE/VEN Architecture
Embedded AI Systems